PAA6 VALUING REDUCED RATES OF OROPHARYNGEAL ADVERSE EVENTS- COMPARISON OF CICLESONIDE WITH FLUTICASONE PROPIONATE
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63608-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)63608-X/fulltext
Section Title :
Section Order :
462
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63608-X&doi=10.1016/S1098-3015(10)63608-X